The levels of Smad4, which shuttles to the nucleus and may directly affect target gene expression by binding to cognate sites in target promoters, reflected those of phospho Smad2/3 with higher basal levels in MDS MSCs (Fig. 1A). The gene discussed is SMAD2; the disease is myelodysplastic syndrome.